Iovance Biotherapeutics Earnings
NASDAQ: IOVAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.09
Iovance Biotherapeutics earnings summary
Iovance Biotherapeutics is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.09. In its most recent report on Aug 6, 2026 (Q2 2026), IOVA posted EPS of $-0.11. Revenue for the quarter was $99.3 million.
Across the last 16 reports, IOVA shares moved an average of 12.1% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
IOVA earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-0.11 | — | +10.1% |
| May 7, 2026 | — | $-0.19 | — | -4.7% |
| Feb 24, 2026 | — | $-0.15 | — | +32.9% |
| Nov 6, 2025 | — | $-0.25 | — | +7.4% |
| Aug 7, 2025 | — | $-0.33 | — | +20.9% |
| May 8, 2025 | — | $-0.36 | — | -5.1% |
| Feb 27, 2025 | — | $-0.24 | — | -11.6% |
| Nov 7, 2024 | — | $-0.28 | — | -22.8% |
| Aug 8, 2024 | — | $-0.34 | — | +5.8% |
| May 9, 2024 | — | $-0.42 | — | -6.7% |
| Feb 28, 2024 | — | $-0.46 | — | -6.5% |
| Nov 7, 2023 | — | $-0.46 | — | +27.2% |
| Aug 8, 2023 | — | $-0.47 | — | -14.0% |
| May 10, 2023 | — | $-0.50 | — | -1.5% |
| Feb 28, 2023 | — | $-0.65 | — | -15.5% |
| Nov 3, 2022 | — | $-0.63 | — | -0.2% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.